Thyrocare Technologies Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Thyrocare Technologies has announced a board meeting to discuss the financial results for the quarter and half-year ended March 31, 2025. Concurrently, the company has received confirmation that its entire shareholding is in demat form, with no requests for rematerialisation during the quarter. This clarity on share status emphasizes operational efficiency and could enhance share liquidity. For investors, the solid dematerialisation position may contribute to a positive outlook, reflecting the company's compliance and streamlined governance, thus fostering confidence among stakeholders.